Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
49
BLOZF Quote, Financials, Valuation and Earnings
Last price:
$0.42
Seasonality move
:
64.07%
Day range:
$0.41 - $0.46
52-week range:
$0.20 - $0.50
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
31.15x
Volume:
93.9K
Avg. volume:
133.8K
1-year change:
84.35%
Market cap:
$51.3M
Revenue:
--
EPS (TTM):
-$0.04
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
BLOZF
Cannabix Technologies, Inc.
|
-- | -- | -- | -- | -- |
|
AXGN
Axogen, Inc.
|
$57.2M | $0.07 | 17.39% | 556.06% | $35.44 |
|
ELMD
Electromed, Inc.
|
$17.8M | -- | 11.04% | -- | $36.00 |
|
IRIX
IRIDEX Corp.
|
$12.8M | -$0.12 | -2.72% | -18.18% | -- |
|
MYO
Myomo, Inc.
|
$10.8M | -$0.07 | -13.8% | -1168.66% | $5.00 |
|
STXS
Stereotaxis, Inc.
|
$9.2M | -$0.06 | 43.22% | -30.79% | $4.20 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
BLOZF
Cannabix Technologies, Inc.
|
$0.42 | -- | $51.3M | -- | $0.00 | 0% | -- |
|
AXGN
Axogen, Inc.
|
$32.80 | $35.44 | $1.5B | -- | $0.00 | 0% | 7.27x |
|
ELMD
Electromed, Inc.
|
$28.50 | $36.00 | $237.7M | 30.66x | $0.00 | 0% | 3.80x |
|
IRIX
IRIDEX Corp.
|
$1.23 | -- | $21.1M | -- | $0.00 | 0% | 0.41x |
|
MYO
Myomo, Inc.
|
$1.02 | $5.00 | $39.2M | -- | $0.00 | 0% | 1.00x |
|
STXS
Stereotaxis, Inc.
|
$2.46 | $4.20 | $229.6M | -- | $0.00 | 0% | 7.25x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
BLOZF
Cannabix Technologies, Inc.
|
5.17% | 0.146 | 0.17% | 5.85x |
|
AXGN
Axogen, Inc.
|
35.99% | -0.858 | 8.25% | 2.56x |
|
ELMD
Electromed, Inc.
|
-- | 1.217 | -- | 4.58x |
|
IRIX
IRIDEX Corp.
|
50.55% | 0.834 | 18.81% | 1.03x |
|
MYO
Myomo, Inc.
|
45.68% | -2.855 | 35.87% | 1.94x |
|
STXS
Stereotaxis, Inc.
|
32.62% | 1.831 | 1.93% | 0.81x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
BLOZF
Cannabix Technologies, Inc.
|
-$30.3K | -$1.8M | -186.45% | -193.08% | -- | -$423.6K |
|
AXGN
Axogen, Inc.
|
$46M | $1.9M | -1.19% | -1.94% | 3.18% | $1.4M |
|
ELMD
Electromed, Inc.
|
$13.2M | $2.7M | 18.88% | 18.89% | 15.81% | -$98K |
|
IRIX
IRIDEX Corp.
|
$4M | -$1.4M | -54.1% | -155.93% | -11.3% | -$1.2M |
|
MYO
Myomo, Inc.
|
$6.4M | -$3.5M | -46.49% | -68.35% | -34.86% | -$2.9M |
|
STXS
Stereotaxis, Inc.
|
$4.1M | -$5.2M | -141.59% | -218.3% | -69.75% | -$4.2M |
Cannabix Technologies, Inc. vs. Competitors
-
Which has Higher Returns BLOZF or AXGN?
Axogen, Inc. has a net margin of -- compared to Cannabix Technologies, Inc.'s net margin of 1.18%. Cannabix Technologies, Inc.'s return on equity of -193.08% beat Axogen, Inc.'s return on equity of -1.94%.
Company Gross Margin Earnings Per Share Invested Capital BLOZFCannabix Technologies, Inc.-- -$0.02 $1.7M AXGNAxogen, Inc.76.55% $0.01 $188.7M -
What do Analysts Say About BLOZF or AXGN?
Cannabix Technologies, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Axogen, Inc. has an analysts' consensus of $35.44 which suggests that it could grow by 8.06%. Given that Axogen, Inc. has higher upside potential than Cannabix Technologies, Inc., analysts believe Axogen, Inc. is more attractive than Cannabix Technologies, Inc..
Company Buy Ratings Hold Ratings Sell Ratings BLOZFCannabix Technologies, Inc.0 0 0 AXGNAxogen, Inc.7 0 0 -
Is BLOZF or AXGN More Risky?
Cannabix Technologies, Inc. has a beta of 0.646, which suggesting that the stock is 35.404% less volatile than S&P 500. In comparison Axogen, Inc. has a beta of 1.062, suggesting its more volatile than the S&P 500 by 6.241%.
-
Which is a Better Dividend Stock BLOZF or AXGN?
Cannabix Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Axogen, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cannabix Technologies, Inc. pays -- of its earnings as a dividend. Axogen, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BLOZF or AXGN?
Cannabix Technologies, Inc. quarterly revenues are --, which are smaller than Axogen, Inc. quarterly revenues of $60.1M. Cannabix Technologies, Inc.'s net income of -$1.8M is lower than Axogen, Inc.'s net income of $708K. Notably, Cannabix Technologies, Inc.'s price-to-earnings ratio is -- while Axogen, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cannabix Technologies, Inc. is -- versus 7.27x for Axogen, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BLOZFCannabix Technologies, Inc.-- -- -- -$1.8M AXGNAxogen, Inc.7.27x -- $60.1M $708K
-
Which has Higher Returns BLOZF or ELMD?
Electromed, Inc. has a net margin of -- compared to Cannabix Technologies, Inc.'s net margin of 12.65%. Cannabix Technologies, Inc.'s return on equity of -193.08% beat Electromed, Inc.'s return on equity of 18.89%.
Company Gross Margin Earnings Per Share Invested Capital BLOZFCannabix Technologies, Inc.-- -$0.02 $1.7M ELMDElectromed, Inc.78.15% $0.25 $44.7M -
What do Analysts Say About BLOZF or ELMD?
Cannabix Technologies, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Electromed, Inc. has an analysts' consensus of $36.00 which suggests that it could grow by 26.32%. Given that Electromed, Inc. has higher upside potential than Cannabix Technologies, Inc., analysts believe Electromed, Inc. is more attractive than Cannabix Technologies, Inc..
Company Buy Ratings Hold Ratings Sell Ratings BLOZFCannabix Technologies, Inc.0 0 0 ELMDElectromed, Inc.4 0 0 -
Is BLOZF or ELMD More Risky?
Cannabix Technologies, Inc. has a beta of 0.646, which suggesting that the stock is 35.404% less volatile than S&P 500. In comparison Electromed, Inc. has a beta of 0.259, suggesting its less volatile than the S&P 500 by 74.113%.
-
Which is a Better Dividend Stock BLOZF or ELMD?
Cannabix Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Electromed, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cannabix Technologies, Inc. pays -- of its earnings as a dividend. Electromed, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BLOZF or ELMD?
Cannabix Technologies, Inc. quarterly revenues are --, which are smaller than Electromed, Inc. quarterly revenues of $16.9M. Cannabix Technologies, Inc.'s net income of -$1.8M is lower than Electromed, Inc.'s net income of $2.1M. Notably, Cannabix Technologies, Inc.'s price-to-earnings ratio is -- while Electromed, Inc.'s PE ratio is 30.66x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cannabix Technologies, Inc. is -- versus 3.80x for Electromed, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BLOZFCannabix Technologies, Inc.-- -- -- -$1.8M ELMDElectromed, Inc.3.80x 30.66x $16.9M $2.1M
-
Which has Higher Returns BLOZF or IRIX?
IRIDEX Corp. has a net margin of -- compared to Cannabix Technologies, Inc.'s net margin of -12.6%. Cannabix Technologies, Inc.'s return on equity of -193.08% beat IRIDEX Corp.'s return on equity of -155.93%.
Company Gross Margin Earnings Per Share Invested Capital BLOZFCannabix Technologies, Inc.-- -$0.02 $1.7M IRIXIRIDEX Corp.32.15% -$0.09 $9.5M -
What do Analysts Say About BLOZF or IRIX?
Cannabix Technologies, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand IRIDEX Corp. has an analysts' consensus of -- which suggests that it could grow by 62.6%. Given that IRIDEX Corp. has higher upside potential than Cannabix Technologies, Inc., analysts believe IRIDEX Corp. is more attractive than Cannabix Technologies, Inc..
Company Buy Ratings Hold Ratings Sell Ratings BLOZFCannabix Technologies, Inc.0 0 0 IRIXIRIDEX Corp.0 0 0 -
Is BLOZF or IRIX More Risky?
Cannabix Technologies, Inc. has a beta of 0.646, which suggesting that the stock is 35.404% less volatile than S&P 500. In comparison IRIDEX Corp. has a beta of 0.652, suggesting its less volatile than the S&P 500 by 34.842%.
-
Which is a Better Dividend Stock BLOZF or IRIX?
Cannabix Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. IRIDEX Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cannabix Technologies, Inc. pays -- of its earnings as a dividend. IRIDEX Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BLOZF or IRIX?
Cannabix Technologies, Inc. quarterly revenues are --, which are smaller than IRIDEX Corp. quarterly revenues of $12.5M. Cannabix Technologies, Inc.'s net income of -$1.8M is lower than IRIDEX Corp.'s net income of -$1.6M. Notably, Cannabix Technologies, Inc.'s price-to-earnings ratio is -- while IRIDEX Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cannabix Technologies, Inc. is -- versus 0.41x for IRIDEX Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BLOZFCannabix Technologies, Inc.-- -- -- -$1.8M IRIXIRIDEX Corp.0.41x -- $12.5M -$1.6M
-
Which has Higher Returns BLOZF or MYO?
Myomo, Inc. has a net margin of -- compared to Cannabix Technologies, Inc.'s net margin of -36.3%. Cannabix Technologies, Inc.'s return on equity of -193.08% beat Myomo, Inc.'s return on equity of -68.35%.
Company Gross Margin Earnings Per Share Invested Capital BLOZFCannabix Technologies, Inc.-- -$0.02 $1.7M MYOMyomo, Inc.63.84% -$0.09 $26.9M -
What do Analysts Say About BLOZF or MYO?
Cannabix Technologies, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Myomo, Inc. has an analysts' consensus of $5.00 which suggests that it could grow by 390.2%. Given that Myomo, Inc. has higher upside potential than Cannabix Technologies, Inc., analysts believe Myomo, Inc. is more attractive than Cannabix Technologies, Inc..
Company Buy Ratings Hold Ratings Sell Ratings BLOZFCannabix Technologies, Inc.0 0 0 MYOMyomo, Inc.4 0 0 -
Is BLOZF or MYO More Risky?
Cannabix Technologies, Inc. has a beta of 0.646, which suggesting that the stock is 35.404% less volatile than S&P 500. In comparison Myomo, Inc. has a beta of 1.026, suggesting its more volatile than the S&P 500 by 2.583%.
-
Which is a Better Dividend Stock BLOZF or MYO?
Cannabix Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Myomo, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cannabix Technologies, Inc. pays -- of its earnings as a dividend. Myomo, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BLOZF or MYO?
Cannabix Technologies, Inc. quarterly revenues are --, which are smaller than Myomo, Inc. quarterly revenues of $10.1M. Cannabix Technologies, Inc.'s net income of -$1.8M is higher than Myomo, Inc.'s net income of -$3.7M. Notably, Cannabix Technologies, Inc.'s price-to-earnings ratio is -- while Myomo, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cannabix Technologies, Inc. is -- versus 1.00x for Myomo, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BLOZFCannabix Technologies, Inc.-- -- -- -$1.8M MYOMyomo, Inc.1.00x -- $10.1M -$3.7M
-
Which has Higher Returns BLOZF or STXS?
Stereotaxis, Inc. has a net margin of -- compared to Cannabix Technologies, Inc.'s net margin of -86.59%. Cannabix Technologies, Inc.'s return on equity of -193.08% beat Stereotaxis, Inc.'s return on equity of -218.3%.
Company Gross Margin Earnings Per Share Invested Capital BLOZFCannabix Technologies, Inc.-- -$0.02 $1.7M STXSStereotaxis, Inc.54.94% -$0.07 $17.1M -
What do Analysts Say About BLOZF or STXS?
Cannabix Technologies, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Stereotaxis, Inc. has an analysts' consensus of $4.20 which suggests that it could grow by 70.73%. Given that Stereotaxis, Inc. has higher upside potential than Cannabix Technologies, Inc., analysts believe Stereotaxis, Inc. is more attractive than Cannabix Technologies, Inc..
Company Buy Ratings Hold Ratings Sell Ratings BLOZFCannabix Technologies, Inc.0 0 0 STXSStereotaxis, Inc.3 0 0 -
Is BLOZF or STXS More Risky?
Cannabix Technologies, Inc. has a beta of 0.646, which suggesting that the stock is 35.404% less volatile than S&P 500. In comparison Stereotaxis, Inc. has a beta of 1.472, suggesting its more volatile than the S&P 500 by 47.244%.
-
Which is a Better Dividend Stock BLOZF or STXS?
Cannabix Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Stereotaxis, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cannabix Technologies, Inc. pays -- of its earnings as a dividend. Stereotaxis, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BLOZF or STXS?
Cannabix Technologies, Inc. quarterly revenues are --, which are smaller than Stereotaxis, Inc. quarterly revenues of $7.5M. Cannabix Technologies, Inc.'s net income of -$1.8M is higher than Stereotaxis, Inc.'s net income of -$6.5M. Notably, Cannabix Technologies, Inc.'s price-to-earnings ratio is -- while Stereotaxis, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cannabix Technologies, Inc. is -- versus 7.25x for Stereotaxis, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BLOZFCannabix Technologies, Inc.-- -- -- -$1.8M STXSStereotaxis, Inc.7.25x -- $7.5M -$6.5M
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
72
GLTO alert for Dec 27
Galecto, Inc. [GLTO] is up 16.92% over the past day.
Sell
20
SMX alert for Dec 27
SMX (Security Matters) Plc [SMX] is down 15.76% over the past day.
Sell
11
CDNAF alert for Dec 27
Canadian Tire Corp. Ltd. [CDNAF] is down 10% over the past day.
